Abstract | OBJECTIVES: METHODS: We immunohistochemically examined the expression pattern of VEGF-A, VEGF-B and VEGFR-1 in 177 invasive breast carcinomas in relation to clinicopathological parameters, p53, c-erbB2 proteins expression and patients' survival. RESULTS:
VEGF-A, VEGF-B and VEGFR-1 were immunodetected predominantly in the cytoplasm of the malignant cells. None of the studied markers correlated with any of the clinicopathological parameters, other than stromal VEGFR-1 which inversely correlated with PR (p=0.021). Cancerous VEGF-A and stromal VEGFR-1 were positively related to p53 (p=0.016 and p=0.033, respectively). Cancerous VEGF-B was positively associated with c-erbB-2 (p=0.045) and was found to exert an unfavorable impact on both disease-free and the overall survival of the node-positive patients (p=0.05 and p=0.029, respectively). Cancerous VEGFR-1 was recognized as being an independent poor prognostic indicator (p=0.037). CONCLUSION: These findings suggest that, while VEGF-B seems to be useful as a prognostic indicator only in node-positive patients, VEGFR-1 may be an independent poor prognosticator in patients with invasive breast carcinoma.
|
Authors | Eleni Mylona, Paraskevi Alexandrou, Ioanna Giannopoulou, George Liapis, Markaki Sofia, Antonios Keramopoulos, Lydia Nakopoulou |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 104
Issue 3
Pg. 557-63
(Mar 2007)
ISSN: 0090-8258 [Print] United States |
PMID | 17150246
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- TP53 protein, human
- Tumor Suppressor Protein p53
- VEGFA protein, human
- VEGFB protein, human
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factor B
- Receptor, ErbB-2
- Vascular Endothelial Growth Factor Receptor-1
|
Topics |
- Breast Neoplasms
(metabolism, pathology)
- Female
- Humans
- Immunohistochemistry
- Neoplasm Invasiveness
- Predictive Value of Tests
- Prognosis
- Receptor, ErbB-2
(biosynthesis)
- Tumor Suppressor Protein p53
(biosynthesis)
- Vascular Endothelial Growth Factor A
(biosynthesis)
- Vascular Endothelial Growth Factor B
(biosynthesis)
- Vascular Endothelial Growth Factor Receptor-1
(biosynthesis)
|